Substrate specificity of radical S-adenosyl-l-methionine dehydratase AprD4 and its partner reductase AprD3 in the C3'-deoxygenation of aminoglycoside antibiotics.
A radical S-adenosyl-l-methionine dehydratase AprD4 and an NADPH-dependent reductase AprD3 are responsible for the C3'-deoxygenation of pseudodisaccharide paromamine in the biosynthesis of apramycin. These enzymes are involved in the construction of the characteristic structural motif that is not modified by 3'-phosphotransferase in aminoglycoside-resistant bacterial strains. AprD4 catalyzes the C3'-dehydration of paromamine via a radical-mediated reaction mechanism to give 4'-oxolividamine, which is then reduced by AprD3 with NADPH to afford lividamine. In the present study, the substrate specificity of this unique combination of enzymes has been investigated. AprD4 was found to recognize paromamine, neamine, kanamycin C, and kanamycin B to afford 5'-deoxyadenosine as one of products during the C3'-dehydration of aminoglycosides, but not 2'-N-acetylparomamine and paromomycin. Only paromamine and kanamycin C were converted to the corresponding C3'-deoxygenated compounds by AprD4 and AprD3. AprD3 recognizes the 4'-oxolividamine moiety, including the pseudotrisaccharide kanamycin C, and seems to reject the amino group at C6' of neamine and kanamycin B. Chirally deuterium-labeled NADPH was used to identify that that AprD3 transfers the pro-S hydrogen atom of NADPH when reducing 4'-oxolividamine to give lividamine.
Department of Chemistry, Tokyo Institute of Technology, Tokyo, Japan.
Fumitaka
F
Kudo
Department of Chemistry, Tokyo Institute of Technology, Tokyo, Japan.
Takahiro
T
Tokumitsu
Department of Chemistry, Tokyo Institute of Technology, Tokyo, Japan.
Tadashi
T
Eguchi
D039903:Actinobacteria / Q000201:enzymology*; D000617:Aminoglycosides / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D006836:Hydro-Lyases / Q000378:metabolism*; D007612:Kanamycin / Q000031:analogs & derivatives; D009249:NADP / Q000378:metabolism; D009328:Nebramycin / Q000031:analogs & derivatives; D013379:Substrate Specificity
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D009328:Nebramycin; C001495:bekanamycin; C011666:apramycin; D009249:NADP; C005936:paromamine; D007612:Kanamycin; D006836:Hydro-Lyases